Hjem › Brystkreft › California › Glendale
Kliniske studier for Brystkreft i Glendale, CA
4 studier for Brystkreft søker deltakere på steder i og rundt Glendale (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Glendale
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Rekrutterer
- Glendale Adventist Medical Center d/b/a Adventist Health Glendale, Glendale
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruttererFase 3
- Los Angeles Cancer Network_Glendale, Glendale
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- Los Angeles Cancer Network - (Admin Only / Central IDS) - No Patients, Glendale
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Glendale
- Major depresjon12 studier
- Ikke-småcellet lungekreft9 studier
- Depresjon6 studier
- Kreft (alle typer)5 studier
- Fedme5 studier
- Kolorektal kreft4 studier
- Lungekreft4 studier
- Metastatisk kreft3 studier
- Koronararteriesykdom3 studier
- Melanom3 studier
- Makulaødem3 studier
- Overvekt3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.